SNS significantly reduced colonic inflammation, similar to the effects of vagus nerve stimulation (VNS), by modulating autonomic function and cytokine production (decreased TNF-α, IL-6, and IL-17A, increased IL-10), indicating potential therapeutic utility for IBD treatment. The gene discussed is IL17A; the disease is inflammatory bowel disease.